Issue Information
4 December 2018
4 December 2018
4 December 2018
4 December 2018
Suzanne R. Sharpton, Germaine J.M. Yong, Norah A. Terrault, Susan V. Lynch – 3 December 2018 – The gut microbiome, the multispecies community of microbes that exists in the gastrointestinal tract, encodes several orders of magnitude more functional genes than the human genome. It also plays a pivotal role in human health, in part due to metabolism of environmental, dietary, and host‐derived substrates, which produce bioactive metabolites.
Lara Dakhoul, Samer Gawrieh, Keaton R. Jones, Marwan Ghabril, Chelsey McShane, Eric Orman, Eduardo Vilar‐Gomez, Naga Chalasani, Lauren Nephew – 3 December 2018 – Black patients have higher mortality and are less likely to receive liver transplantation for hepatocellular carcinoma (HCC) than white patients. Reasons for these disparities have not been fully elucidated.
Nashila AbdulRahim, Lee Anderson, Suman Kotla, Hao Liu, Venkatesh K. Ariyamuthu, Mythili Ghanta, Malcolm MacConmara, Shannan R. Tujios, Arjmand Mufti, Sumit Mohan, Jorge A. Marrero, Parsia A. Vagefi, Bekir Tanriover – 2 December 2018 – The number of simultaneous liver‐kidney transplantations (SLKTs) and use of induction therapy for SLKT have increased recently, without much published evidence, especially in the context of maintenance immunosuppression containing tacrolimus (TAC) and mycophenolic acid (MPA).
Iris E.M. de Jong, Alix P.M. Matton, Jasper B. van Praagh, Wouter T. van Haaften, Janneke Wiersema‐Buist, Louise A. van Wijk, Dorenda Oosterhuis, Raditya Iswandana, Su Suriguga, Diletta Overi, Ton Lisman, Guido Carpino, Annette S.H. Gouw, Peter Olinga, Eugenio Gaudio, Robert J. Porte – 2 December 2018 – Peribiliary glands (PBG) are a source of stem/progenitor cells organized in a cellular network encircling large bile ducts.
Eduardo Vilar‐Gomez, Raj Vuppalanchi, Samer Gawrieh, Marwan Ghabril, Romil Saxena, Oscar W. Cummings, Naga Chalasani – 1 December 2018 – Vitamin E improves liver histology in adults with nonalcoholic steatohepatitis (NASH) but not diabetes, but its impact on long‐term patient outcomes is unknown. We evaluated whether vitamin E treatment improves clinical outcomes of NASH patients with bridging fibrosis or cirrhosis.
Jian‐Hong Fang, Li Xu, Li‐Ru Shang, Chu‐Zhi Pan, Jin Ding, Yun‐Qiang Tang, Hui Liu, Chu‐Xing Liu, Jia‐Lin Zheng, Yao‐Jun Zhang, Zhong‐Guo Zhou, Jing Xu, Limin Zheng, Min‐Shan Chen, Shi‐Mei Zhuang – 1 December 2018 – Sorafenib is the most recommended first‐line systemic therapy for advanced hepatocellular carcinoma (HCC). Yet there is no clinically applied biomarker for predicting sorafenib response.
Yanan Ma, Wanshui Yang, Tracey G. Simon, Stephanie A. Smith‐Warner, Teresa T. Fung, Jing Sui, Dawn Chong, Trang VoPham, Jeffrey A. Meyerhardt, Deliang Wen, Edward L. Giovannucci, Andrew T. Chan, Xuehong Zhang – 1 December 2018 – Although adherence to healthy dietary guidelines has been associated with a reduced risk of several health outcomes, including cardiovascular diseases, type 2 diabetes, and some cancers, little is known about the role of dietary patterns in the development of hepatocellular carcinoma (HCC).